semaglutide blindness study Ozempic Sudden Semaglutide may cause blindness—US study

Most are mild and manageable, but some can be more serious

The growing influence of GLP-1 therapies may be a catalyst for some of those shifts

We pair this with other methods of weight loss, like lipotropic injections, appetite suppressants, vitamins, and managing diet and exercise

Common side effects include: Nausea Vomiting Diarrhea Stomach pain Constipation Reduced appetite More serious risks may involve: Thyroid concerns Pancreatitis Gallbladder issues Vision changes Severe gastrointestinal (GI) complications Allergic reactions A healthcare provider should review your medical history before starting treatment

For years, its role in weight management was less understood, but more recent research suggests GIP receptor activation may enhance the bodys sensitivity to GLP-1, improve fat metabolism, and further support appetite regulation